3 results
Approved WMOCompleted
Time to recurrence of sustained VT and/or appropriate ICD therapy; ATP or shock
Approved WMORecruiting
The main objective is to evaluate the average time span within which *time of onset* and *time of offset* occurs in patients with overactive bladder syndrome or non-obstructive urinary retention who respond to SNM.
Approved WMOPending
This study is evaluating the preliminary efficacy of UV1-olaparib-durvalumab combination against both olaparib as monotherapy and olaparib-durvalumab combination in maintenance after platinum combination therapy for BRCAwt patients with relapsed…